News from the UW Initiative to End Alzheimer's
UW study focuses on Alzheimer’s disease treatment and prevention in the Black community
Carey Gleason, PhD, MS, and her research team’s African Americans Fighting Alzheimer's in Midlife (AA-FAIM) study is entering its second, five-year cycle and they are focused on making Alzheimer’s research more inclusive.
February 2, 2023Dr. Maria Mora Pinzon appointed to assistant professor
Maria Mora Pinzon, MD, MS, FACPM, was recently appointed to assistant professor on the tenure track in the Division of Geriatrics and Gerontology at the University of Wisconsin School of Medicine and Public Health, where she will continue working with the Wisconsin Alzheimer’s Institute and expand her research program.
February 2, 2023Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval
On the latest episode of the podcast, Dementia Matters, host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials.
January 18, 2023Dr. Nathaniel Chin discusses the FDA approval of Leqembi on WPR
Nathaniel Chin, MD, joined host Rob Ferrett on the call-in program “Central Time” on The Ideas Network of Wisconsin Public Radio. Chin discussed the recent FDA approval of the drug Leqembi (lecanemab) to help with early Alzheimer's and answered callers’ questions.
January 12, 2023Dr. Cynthia Carlsson discusses the FDA approval of Leqembi
Cynthia Carlsson, MD, MS, was recently interviewed by CBS 58 News in Milwaukee about the U.S. Food and Drug Administration (FDA) approval of Leqembi (lecanemab), which showed a reduction of clinical decline in a study of people with early Alzheimer’s disease.
January 12, 2023FDA approves Alzheimer’s disease drug lecanemab
On January 6, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease.
January 12, 2023Dr. Sanjay Asthana appointed to serve on the National Advisory Council on Aging
Sanjay Asthana, MD, is the founding director of the Wisconsin Alzheimer’s Disease Research Center (ADRC) and an internationally renowned researcher and leader in the field of Alzheimer’s disease. The US Secretary of Health and Human …
January 12, 2023